本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vor Biopharma Inc.

1.96
+0.03001.55%
盘后1.95-0.0092-0.47%19:15 EDT
成交量:305.95万
成交额:599.39万
市值:2.48亿
市盈率:-0.11
高:2.02
开:1.95
低:1.90
收:1.93
52周最高:3.29
52周最低:0.1311
股本:1.27亿
流通股本:4,761.74万
量比:0.73
换手率:6.43%
股息:- -
股息率:- -
每股收益(TTM):-17.1330
每股收益(LYR):-1.7017
净资产收益率:-125.43%
总资产收益率:-121.29%
市净率:-0.16
市盈率(LYR):-1.15

数据加载中...

2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/22

重要事件披露

Form 8-K - Current report
2025/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC.高管 Robert Ang 拟减持214135股,总价约52万美元
2025/07/10

重要事件披露

Form 8-K - Current report
2025/07/10

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持596885股,总价约138.8万美元
2025/07/03

关联方拟减持公告

Form 144 | VOR BIOPHARMA高管 Robert Ang 拟减持44936股,总价约8.04万美元
2025/07/01

关联方拟减持公告

Form 144 | VOR BIOPHARMA高管Robert Ang拟减持40468股,总价约69613美元
2025/06/30

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持40627股,总价约70289美元
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/21

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report